Literature DB >> 497709

Occupational handling of chemicals preceding Hodgkin's disease in men.

H Olsson, L Brandt.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 497709      PMCID: PMC1596520          DOI: 10.1136/bmj.2.6190.580-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Epidemiology of Hodgkin's disease.

Authors:  B MacMahon
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

2.  Leukaemia and Hodgkin's disease among Swedish chemistry graduates.

Authors:  R Olin
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

  2 in total
  7 in total

1.  Lymphohaematopoietic malignancy around all industrial complexes that include major oil refineries in Great Britain.

Authors:  P Wilkinson; B Thakrar; P Walls; M Landon; S Falconer; C Grundy; P Elliott
Journal:  Occup Environ Med       Date:  1999-09       Impact factor: 4.402

2.  Hodgkin's disease and occupational exposure to chemicals.

Authors:  R T Benn; A Mangood; A Smith
Journal:  Br Med J       Date:  1979-11-03

Review 3.  Assessment of the risks associated with the use of chemical carcinogens in biomedical research.

Authors:  E B Sansone
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Leukaemia and lymphoma risks derived from solvents.

Authors:  L Brandt
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

5.  Case-control studies in cancer patients as a surveillance system of occupational exposure in the European Community. European Community Working Party.

Authors:  R J Rona; N A Taub; S Rasmussen
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

6.  Occupation and lymphoid neoplasms.

Authors:  C La Vecchia; E Negri; B D'Avanzo; S Franceschi
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

Review 7.  Hematotoxicity and carcinogenicity of benzene.

Authors:  M Aksoy
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.